输血相关含铁血黄素沉着致脾脏弥漫性摄取的骨显像与MRI对照
一例70岁乳腺癌女性,因治疗后骨髓转移所致难治性贫血多次输血,实验室检查AST 50 U/L、ALT 115 U/L。99mTc MDP骨显像示脾脏弥漫性浓聚,增强CT未见脾钙化或梗死,MRI示脾、肝T2显著低信号,提示输血相关继发性含铁血黄素沉着。
要点
- 骨显像脾弥漫性摄取需考虑铁过载可能
- 增强CT无脾钙化或梗死时,MRI有助于鉴别
- MRI脾肝T2低信号支持继发性含铁血黄素沉着
核心结论
- 骨显像发现脾脏弥漫性摄取时,应将铁过载纳入考虑。
研究设计与样本
- 个案报道:1例70岁女性乳腺癌患者,因治疗后骨髓转移所致难治性贫血多次输血。
- 影像对照:99mTc MDP骨显像与增强CT、MRI结果对照。
主要发现
- 99mTc MDP骨显像示脾脏弥漫性浓聚。
- 增强CT未见脾钙化或梗死。
- MRI示脾、肝T2显著低信号,未见脾局灶性病变。
关键数值与推荐
- 实验室检查:AST 50 U/L、ALT 115 U/L。
临床怎么用
- 骨显像见脾弥漫性摄取时,结合输血史并考虑MRI评估铁过载。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
A 70-year-old woman with a past medical history of breast cancer is undergoing surveillance. She also had a history of repeated blood transfusions for refractory anemia caused by treated marrow metastatic disease. Laboratory tests showed elevated AST (50 U/L) and ALT (115 U/L). 99m Tc MDP bone scintigraphy revealed intense diffuse splenic uptake. No splenic calcifications or infarcts were found on contrast-enhanced CT. MRI demonstrated signal dropout on in-phase sequences and marked T2 hypointensity of the spleen and liver, without focal splenic lesions, suggesting transfusion-related secondary hemosiderosis. Iron overload should be considered when diffuse splenic uptake is observed on bone scintigraphy.
引用
- Mohamed OAE, ElSayes KM, Morton K, et al. Diffuse Splenic Uptake on 99m Tc MDP Bone Scintigraphy Secondary to Transfusion-Related Hemosiderosis : Correlation With MRI Findings. Clin Nucl Med. 2026. PMID: 42307418. doi:10.1097/RLU.0000000000006580
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。